BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 23643282)

  • 1. OCT analysis in patients with very late stent thrombosis.
    Kang SJ; Lee CW; Song H; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Mintz GS; Park SW; Park SJ
    JACC Cardiovasc Imaging; 2013 Jun; 6(6):695-703. PubMed ID: 23643282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure Mechanisms and Neoatherosclerosis Patterns in Very Late Drug-Eluting and Bare-Metal Stent Thrombosis.
    Nakamura D; Attizzani GF; Toma C; Sheth T; Wang W; Soud M; Aoun R; Tummala R; Leygerman M; Fares A; Mehanna E; Nishino S; Fung A; Costa MA; Bezerra HG
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
    Kitabata H; Loh JP; Pendyala LK; Omar A; Ota H; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2014 Apr; 15(3):149-55. PubMed ID: 24767313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium).
    Joner M; Koppara T; Byrne RA; Castellanos MI; Lewerich J; Novotny J; Guagliumi G; Xhepa E; Adriaenssens T; Godschalk TC; Malik N; Alfonso F; Tada T; Neumann FJ; Desmet W; Ten Berg JM; Gershlick AH; Feldman LJ; Massberg S; Kastrati A;
    JACC Cardiovasc Interv; 2018 Jul; 11(14):1340-1350. PubMed ID: 30025727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Earlier Versus Delayed Presentation of Very Late Drug-Eluting Stent Thrombosis: An Optical Coherence Tomographic Study.
    Lee SY; Ahn JM; Mintz GS; Hur SH; Choi SY; Kim SW; Cho JM; Hong SJ; Kim JW; Hong YJ; Lee SG; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Park SJ; Hong MK
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late and very late coronary stent thrombosis: Intravascular ultrasound findings and associations with antiplatelet therapy.
    Pesarini G; Dandale R; Rigamonti A; Pighi M; Zivelonghi C; Mugnolo A; Ferrero V; Vassanelli C; Ribichini F
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1056-65. PubMed ID: 23592553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-Year Optical Coherence Tomography in Patients With ST-Segment-Elevation Myocardial Infarction Treated With Bare-Metal Versus Everolimus-Eluting Stents.
    Gomez-Lara J; Brugaletta S; Jacobi F; Ortega-Paz L; Ñato M; Roura G; Romaguera R; Ferreiro JL; Teruel L; Gracida M; Martin-Yuste V; Freixa X; Masotti M; Gomez-Hospital JA; Sabate M; Cequier A
    Circ Cardiovasc Interv; 2016 Oct; 9(10):. PubMed ID: 27702766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stent malapposition, as a potential mechanism of very late stent thrombosis after bare-metal stent implantation: a case report.
    Higuma T; Abe N; Hanada K; Yokoyama H; Tomita H; Okumura K
    Cardiovasc Revasc Med; 2014 Apr; 15(3):178-81. PubMed ID: 24139450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
    Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neointimal tissue component assessed by tissue characterization with 40 MHz intravascular ultrasound imaging: comparison of drug-eluting stents and bare-metal stents.
    Tsujita K; Takaoka N; Kaikita K; Hokimoto S; Horio E; Sato K; Mizobe M; Nakayama N; Kojima S; Tayama S; Sugiyama S; Nakamura S; Ogawa H
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1068-74. PubMed ID: 23460385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation.
    Ko YG; Kim DM; Cho JM; Choi SY; Yoon JH; Kim JS; Kim BK; Choi D; Jang Y; Hong MK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):715-23. PubMed ID: 21656060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation.
    Lee CW; Kang SJ; Park DW; Lee SH; Kim YH; Kim JJ; Park SW; Mintz GS; Park SJ
    J Am Coll Cardiol; 2010 May; 55(18):1936-42. PubMed ID: 20430265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
    Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality visualization with 3-dimensional reconstruction of neointimal plaque rupture after bare-metal stent implantation.
    Sudo M; Hiro T; Takayama T; Iida K; Nishida T; Kawano T; Kanai T; Higuchi Y; Hirayama A
    JACC Cardiovasc Interv; 2014 Oct; 7(10):e163-5. PubMed ID: 25240542
    [No Abstract]   [Full Text] [Related]  

  • 18. Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis.
    Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):564-72. PubMed ID: 25158217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions.
    Choi W; Chae IH; Park JJ; Kim SH; Kang SH; Oh IY; Yoon CH; Cho YS; Youn TJ; Choi DJ
    Korean J Intern Med; 2019 Jul; 34(4):819-829. PubMed ID: 29961306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.